In his State of the Union address last night, President Obama said he wants to “make America the country that cures cancer once and for all.”
A key piece of that “moonshot” – as the president and vice president have called it – may be a treatment that’s still very much in the experimental phase: personalized cancer vaccines.
Here & Now’s Jeremy Hobson talks with STAT senior science writer Sharon Begley about how those personalized vaccines – called neoantigen vaccines – work, and why they could become a central player in the push to cure cancer.
Guest
- Sharon Begley, senior science writer at STAT. She tweets @sxbegle.
Copyright 2016 NPR. To see more, visit NPR.
300x250 Ad
300x250 Ad